XII Medical, Inc. raised $45 million in a Series B financing led by Omega Funds and Intuitive Ventures to advance their neuromodulation therapy for obstructive sleep apnea.
Aug 21, 2024•over 1 year ago
Amount Raised
$45 Million
Round Type
series b
Union CityInvestors
Undisclosed Strategic InvestorJobs Ohio Growth Capital FundAperture Venture PartnersLongview VenturesAjax HealthCleveland ClinicIntuitive VenturesOmega Funds
Description
XII Medical, Inc. announced the closing of a $45 million Series B equity financing to further product and clinical development of its innovative therapy for obstructive sleep apnea. The financing was led by Omega Funds and included participation from various existing and new investors.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech